Skip to main content

Table 4 VFQ-39 total scores stratified by visits, treatment type, and disease activity

From: Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

  Baseline Month 6 Difference P value
Treatment type     
 Group 1 73.59 78.08 4.49 0.090
 Group 2 71.16 80.71 9.54 0.005
Disease activity     
 Category 1 57.95 69.24 11.28 0.057
 Category 2 77.09 83.78 6.69 0.027
 Category 3 77.77 81.87 4.09 0.2209
  1. P values were calculated using paired t test.